Agios Pharmaceuticals, Inc. (AGIO) · Insider trading

What Agios Pharmaceuticals's directors, officers and largest holders bought and sold themselves, from the Form 4 each of them files with the SEC within two business days of a trade. Open-market purchases and sales first: those are the trades somebody chose to make at the market price.

Bought, 12 months

0 insiders, 0 trades

Sold, 12 months

$4.76M

8 insiders, 97% under a plan

Net, 12 months

−$4.76M

bought less sold

Latest filing

2026-08-06

filings read to 2026-10-19

Bought and sold at the market, by month

Two years. Purchases above the line, sales below, in dollars.

Bought Sold Largest month: $2.30M

Who traded, two years

Insider	Bought	Sold	Trades	Last trade	Holds after
Goff BrianDirector, Chief Executive Officer	–	$3.19M	12	2026-04-02	177,604
Gheuens SarahChief Medical Officer	–	$2.46M	17	2026-08-04	54,645
Burns James WilliamChief Legal Officer	–	$1.72M	12	2026-04-02	49,306
Ballal Rahul D.Director	–	$1.12M	5	2024-11-08	14,421
Washburn Theodore James Jr.Principal Accounting Officer	–	$711,979	10	2026-03-03	868
Jones CeciliaChief Financial Officer	–	$609,068	10	2026-04-02	54,998
Milanova TsvetaChief Commercial Officer	–	$596,192	8	2026-04-02	46,829
Fouse Jacqualyn ADirector	–	$194,172	1	2025-04-10	149,220
Viswanadhan KrishnanChief Corp Dev & Strategy	–	$184,967	2	2026-04-02	10,282
Scadden DavidDirector	–	$98,224	6	2025-11-12	17,603

Open-market purchases and sales

Newest first. “Plan” marks a trade made under a 10b5-1 plan set up in advance.

Date	Insider	Trade	Shares	Price	Value	Holds after	Filing
2026-08-04	Gheuens SarahChief Medical Officer	Saleplan	30,000	30.48	$914,400	54,645	Form 4
2026-07-01	Gheuens SarahChief Medical Officer	Saleplan	4,007	37.56	$150,503	84,645	Form 4
2026-04-02	Goff BrianDirector, Chief Executive Officer	Saleplan	12,472	34.71	$432,903	177,604	Form 4
2026-04-02	Goff BrianDirector, Chief Executive Officer	Saleplan	6,596	34.71	$228,947	184,508	Form 4
2026-04-02	Viswanadhan KrishnanChief Corp Dev & Strategy	Saleplan	2,959	34.71	$102,707	10,282	Form 4
2026-04-02	Milanova TsvetaChief Commercial Officer	Saleplan	3,262	34.71	$113,224	46,829	Form 4
2026-04-02	Jones CeciliaChief Financial Officer	Saleplan	3,141	34.71	$109,024	54,998	Form 4
2026-04-02	Gheuens SarahChief Medical Officer	Saleplan	2,940	34.71	$102,047	80,277	Form 4
2026-04-02	Burns James WilliamChief Legal Officer	Saleplan	3,280	34.71	$113,849	49,306	Form 4
2026-03-05	Viswanadhan KrishnanChief Corp Dev & Strategy	Saleplan	2,959	27.80	$82,260	5,141	Form 4
2026-03-03	Washburn Theodore James Jr.Principal Accounting Officer	Sale	5,272	28.88	$152,255	868	Form 4
2026-03-02	Washburn Theodore James Jr.Principal Accounting Officer	Saleplan	698	28.96	$20,214	2,595	Form 4
2026-03-02	Washburn Theodore James Jr.Principal Accounting Officer	Saleplan	727	28.96	$21,054	4,243	Form 4
2026-03-02	Washburn Theodore James Jr.Principal Accounting Officer	Saleplan	798	28.96	$23,110	6,140	Form 4
2026-03-02	Milanova TsvetaChief Commercial Officer	Saleplan	1,681	28.96	$48,682	38,778	Form 4
2026-03-02	Milanova TsvetaChief Commercial Officer	Saleplan	1,187	28.96	$34,376	41,591	Form 4
2026-03-02	Jones CeciliaChief Financial Officer	Saleplan	594	28.96	$17,202	38,800	Form 4
2026-03-02	Jones CeciliaChief Financial Officer	Saleplan	1,681	28.96	$48,682	42,785	Form 4
2026-03-02	Jones CeciliaChief Financial Officer	Saleplan	1,187	28.96	$34,376	45,598	Form 4
2026-03-02	Jones CeciliaChief Financial Officer	Saleplan	1,573	28.96	$45,554	49,328	Form 4
2026-03-02	Gheuens SarahChief Medical Officer	Saleplan	1,187	28.96	$34,376	67,608	Form 4
2026-03-02	Gheuens SarahChief Medical Officer	Saleplan	1,681	28.96	$48,682	71,593	Form 4
2026-03-02	Gheuens SarahChief Medical Officer	Saleplan	1,187	28.96	$34,376	74,406	Form 4
2026-03-02	Burns James WilliamChief Legal Officer	Saleplan	1,187	28.96	$34,376	34,531	Form 4
2026-03-02	Burns James WilliamChief Legal Officer	Saleplan	1,681	28.96	$48,682	38,516	Form 4
2026-03-02	Burns James WilliamChief Legal Officer	Saleplan	1,187	28.96	$34,376	41,329	Form 4
2026-03-02	Burns James WilliamChief Legal Officer	Saleplan	1,163	28.96	$33,680	44,086	Form 4
2026-03-02	Goff BrianDirector, Chief Executive Officer	Saleplan	3,870	28.96	$112,075	147,733	Form 4
2026-03-02	Goff BrianDirector, Chief Executive Officer	Saleplan	8,267	28.96	$239,412	157,466	Form 4
2026-03-02	Goff BrianDirector, Chief Executive Officer	Saleplan	5,918	28.96	$171,385	164,548	Form 4
2026-01-05	Milanova TsvetaChief Commercial Officer	Saleplan	2,872	27.02	$77,601	34,793	Form 4
2025-12-30	Jones CeciliaChief Financial Officer	Saleplan	2,932	27.09	$79,428	37,394	Form 4
2025-12-30	Milanova TsvetaChief Commercial Officer	Saleplan	2,932	27.09	$79,428	29,190	Form 4
2025-12-30	Gheuens SarahChief Medical Officer	Saleplan	2,932	27.09	$79,428	64,795	Form 4
2025-12-30	Goff BrianDirector, Chief Executive Officer	Saleplan	12,473	27.09	$337,894	136,583	Form 4
2025-12-30	Goff BrianDirector, Chief Executive Officer	Saleplan	6,230	27.09	$168,771	143,103	Form 4
2025-12-30	Burns James WilliamChief Legal Officer	Saleplan	2,932	27.09	$79,428	31,718	Form 4
2025-11-12	Scadden DavidDirector	Saleplan	200	43.84	$8,768	17,603	Form 4
2025-11-11	Gheuens SarahChief Medical Officer	Saleplan	2,454	43.78	$107,436	61,727	Form 4
2025-10-30	Gheuens SarahChief Medical Officer	Saleplan	200	43.81	$8,762	61,727	Form 4

43 more

2025-10-27	Gheuens SarahChief Medical Officer	Saleplan	3,302	43.92	$145,024	61,727	Form 4
2025-10-08	Scadden DavidDirector	Saleplan	200	41.00	$8,200	17,603	Form 4
2025-09-30	Scadden DavidDirector	Saleplan	200	40.00	$8,000	17,603	Form 4
2025-09-26	Jones CeciliaChief Financial Officer	Saleplan	3,651	36.77	$134,247	33,870	Form 4
2025-09-05	Washburn Theodore James Jr.Principal Accounting Officer	Sale	8,546	36.87	$315,091	868	Form 4
2025-08-27	Scadden DavidDirector	Saleplan	200	40.00	$8,000	17,603	Form 4
2025-08-08	Goff BrianDirector, Chief Executive Officer	Saleplan	11,085	36.67	$406,487	123,528	Form 4
2025-07-10	Scadden DavidDirector	Saleplan	1,400	40.00	$56,000	17,603	Form 4
2025-07-09	Gheuens SarahChief Medical Officer	Saleplan	11,067	37.93	$419,771	62,118	Form 4
2025-07-09	Gheuens SarahChief Medical Officer	Saleplan	847	38.76	$32,830	61,271	Form 4
2025-07-01	Gheuens SarahChief Medical Officer	Saleplan	4,091	34.17	$139,789	61,271	Form 4
2025-06-24	Goff BrianDirector, Chief Executive Officer	Saleplan	12,471	33.54	$418,277	105,401	Form 4
2025-06-24	Goff BrianDirector, Chief Executive Officer	Saleplan	6,229	33.54	$208,921	111,922	Form 4
2025-06-24	Milanova TsvetaChief Commercial Officer	Saleplan	2,770	33.54	$92,906	26,122	Form 4
2025-06-24	Jones CeciliaChief Financial Officer	Saleplan	1,780	33.54	$59,701	30,049	Form 4
2025-06-24	Gheuens SarahChief Medical Officer	Saleplan	2,909	33.54	$97,568	56,988	Form 4
2025-06-24	Burns James WilliamChief Legal Officer	Saleplan	2,799	33.54	$93,878	28,650	Form 4
2025-04-10	Fouse Jacqualyn ADirector	Saleplan	7,497	25.90	$194,172	149,220	Form 4
2025-03-03	Washburn Theodore James Jr.Principal Accounting Officer	Saleplan	231	35.54	$8,210	6,038	Form 4
2025-03-03	Washburn Theodore James Jr.Principal Accounting Officer	Saleplan	697	35.54	$24,771	7,691	Form 4
2025-03-03	Washburn Theodore James Jr.Principal Accounting Officer	Saleplan	727	35.54	$25,838	9,414	Form 4
2025-03-03	Gheuens SarahChief Medical Officer	Saleplan	1,137	35.54	$40,409	47,098	Form 4
2025-03-03	Gheuens SarahChief Medical Officer	Saleplan	1,187	35.54	$42,186	49,911	Form 4
2025-03-03	Gheuens SarahChief Medical Officer	Saleplan	1,681	35.54	$59,743	53,897	Form 4
2025-03-03	Goff BrianDirector, Chief Executive Officer	Saleplan	4,153	35.54	$147,598	83,139	Form 4
2025-03-03	Goff BrianDirector, Chief Executive Officer	Saleplan	8,794	35.54	$312,539	92,345	Form 4
2025-03-03	Milanova TsvetaChief Commercial Officer	Saleplan	1,681	35.54	$59,743	22,892	Form 4
2025-03-03	Jones CeciliaChief Financial Officer	Saleplan	594	35.54	$21,111	21,843	Form 4
2025-03-03	Jones CeciliaChief Financial Officer	Saleplan	1,681	35.54	$59,743	25,829	Form 4
2025-03-03	Burns James WilliamChief Legal Officer	Saleplan	1,137	35.54	$40,409	18,650	Form 4
2025-03-03	Burns James WilliamChief Legal Officer	Saleplan	1,187	35.54	$42,186	21,463	Form 4
2025-03-03	Burns James WilliamChief Legal Officer	Saleplan	1,681	35.54	$59,743	25,449	Form 4
2025-02-05	Washburn Theodore James Jr.Principal Accounting Officer	Saleplan	2,272	34.39	$78,134	5,437	Form 4
2025-01-06	Milanova TsvetaChief Commercial Officer	Saleplan	2,804	32.18	$90,233	18,906	Form 4
2024-12-11	Scadden DavidDirector	Saleplan	200	46.28	$9,256	15,483	Form 4
2024-11-08	Washburn Theodore James Jr.Principal Accounting Officer	Sale	772	56.09	$43,301	813	Form 4
2024-11-08	Ballal Rahul D.Director	Saleplan	3,571	57.24	$204,404	14,421	Form 4
2024-11-08	Ballal Rahul D.Director	Saleplan	4,929	58.57	$288,692	9,492	Form 4
2024-11-08	Ballal Rahul D.Director	Saleplan	1,500	59.21	$88,815	7,992	Form 4
2024-11-07	Burns James WilliamChief Legal Officer	Saleplan	13,411	52.00	$697,372	24,041	Form 4
2024-11-07	Burns James WilliamChief Legal Officer	Saleplan	8,341	52.56	$438,403	15,700	Form 4
2024-11-07	Ballal Rahul D.Director	Saleplan	8,132	53.32	$433,598	9,860	Form 4
2024-11-07	Ballal Rahul D.Director	Saleplan	1,868	54.41	$101,638	7,992	Form 4

Grants, exercises and other transactions

Pay, tax and paperwork rather than a choice to trade at the market price. Two years.

95 × option exercise1 × grant or award

Show them

Date	Insider	What	Shares	Price	Holds after	Filing
2026-07-08	Backstrom Jay T.Director	Grant or award A	+1,447	–	1,447	Form 4
2026-07-01	Gheuens SarahChief Medical Officer	Option exercise M	+8,375	–	88,652	Form 4
2026-06-18	Smith CynthiaDirector	Option exercise M	+2,816	–	15,230	Form 4
2026-06-18	Scadden DavidDirector	Option exercise M	+2,816	–	20,419	Form 4
2026-06-18	Owen Adams CatherineDirector	Option exercise M	+2,816	–	10,865	Form 4
2026-06-18	Ho MaykinDirector	Option exercise M	+2,816	–	19,848	Form 4
2026-06-18	Fouse Jacqualyn ADirector	Option exercise M	+2,816	–	154,156	Form 4
2026-06-18	Foster-Cheek Kaye IDirector	Option exercise M	+2,816	–	10,284	Form 4
2026-06-18	Capello Jeffrey DDirector	Option exercise M	+2,816	–	10,865	Form 4
2026-06-18	Ballal Rahul D.Director	Option exercise M	+2,816	–	15,230	Form 4
2026-06-13	Capello Jeffrey DDirector	Option exercise M	+1,976	–	8,049	Form 4
2026-06-13	Owen Adams CatherineDirector	Option exercise M	+1,976	–	8,049	Form 4
2026-04-02	Goff BrianDirector, Chief Executive Officer	Option exercise M	+25,528	–	190,076	Form 4
2026-04-02	Goff BrianDirector, Chief Executive Officer	Option exercise M	+13,500	–	191,104	Form 4
2026-04-02	Viswanadhan KrishnanChief Corp Dev & Strategy	Option exercise M	+8,100	–	13,241	Form 4
2026-04-02	Milanova TsvetaChief Commercial Officer	Option exercise M	+8,500	–	50,091	Form 4
2026-04-02	Jones CeciliaChief Financial Officer	Option exercise M	+8,500	–	58,139	Form 4
2026-04-02	Gheuens SarahChief Medical Officer	Option exercise M	+8,500	–	83,217	Form 4
2026-04-02	Burns James WilliamChief Legal Officer	Option exercise M	+8,500	–	52,586	Form 4
2026-03-05	Viswanadhan KrishnanChief Corp Dev & Strategy	Option exercise M	+8,100	–	8,100	Form 4
2026-03-02	Washburn Theodore James Jr.Principal Accounting Officer	Option exercise M	+2,350	–	3,293	Form 4
2026-03-02	Washburn Theodore James Jr.Principal Accounting Officer	Option exercise M	+2,450	–	4,970	Form 4
2026-03-02	Washburn Theodore James Jr.Principal Accounting Officer	Option exercise M	+2,695	–	6,938	Form 4
2026-03-02	Milanova TsvetaChief Commercial Officer	Option exercise M	+5,666	–	40,459	Form 4
2026-03-02	Milanova TsvetaChief Commercial Officer	Option exercise M	+4,000	–	42,778	Form 4
2026-03-02	Jones CeciliaChief Financial Officer	Option exercise M	+2,000	–	39,394	Form 4
2026-03-02	Jones CeciliaChief Financial Officer	Option exercise M	+5,666	–	44,466	Form 4
2026-03-02	Jones CeciliaChief Financial Officer	Option exercise M	+4,000	–	46,785	Form 4
2026-03-02	Jones CeciliaChief Financial Officer	Option exercise M	+5,303	–	50,901	Form 4
2026-03-02	Gheuens SarahChief Medical Officer	Option exercise M	+4,000	–	68,795	Form 4
2026-03-02	Gheuens SarahChief Medical Officer	Option exercise M	+5,666	–	73,274	Form 4
2026-03-02	Gheuens SarahChief Medical Officer	Option exercise M	+4,000	–	75,593	Form 4
2026-03-02	Burns James WilliamChief Legal Officer	Option exercise M	+4,000	–	35,718	Form 4
2026-03-02	Burns James WilliamChief Legal Officer	Option exercise M	+5,666	–	40,197	Form 4
2026-03-02	Burns James WilliamChief Legal Officer	Option exercise M	+4,000	–	42,516	Form 4
2026-03-02	Burns James WilliamChief Legal Officer	Option exercise M	+3,920	–	45,249	Form 4
2026-03-02	Goff BrianDirector, Chief Executive Officer	Option exercise M	+8,500	–	151,603	Form 4
2026-03-02	Goff BrianDirector, Chief Executive Officer	Option exercise M	+18,000	–	165,733	Form 4
2026-03-02	Goff BrianDirector, Chief Executive Officer	Option exercise M	+13,000	–	170,466	Form 4
2026-01-05	Milanova TsvetaChief Commercial Officer	Option exercise M	+8,475	–	37,665	Form 4
2025-12-30	Jones CeciliaChief Financial Officer	Option exercise M	+6,000	–	40,326	Form 4
2025-12-30	Milanova TsvetaChief Commercial Officer	Option exercise M	+6,000	–	32,122	Form 4
2025-12-30	Gheuens SarahChief Medical Officer	Option exercise M	+6,000	–	67,727	Form 4
2025-12-30	Goff BrianDirector, Chief Executive Officer	Option exercise M	+25,528	–	149,056	Form 4
2025-12-30	Goff BrianDirector, Chief Executive Officer	Option exercise M	+12,750	–	149,333	Form 4
2025-12-30	Burns James WilliamChief Legal Officer	Option exercise M	+6,000	–	34,650	Form 4
2025-11-12	Scadden DavidDirector	Option exercise M	+200	18.09	17,803	Form 4
2025-11-11	Gheuens SarahChief Medical Officer	Option exercise M	+2,454	25.01	64,181	Form 4
2025-10-30	Gheuens SarahChief Medical Officer	Option exercise M	+200	25.01	61,927	Form 4
2025-10-27	Gheuens SarahChief Medical Officer	Option exercise M	+3,302	25.01	65,029	Form 4
2025-10-08	Scadden DavidDirector	Option exercise M	+200	18.09	17,803	Form 4
2025-09-30	Scadden DavidDirector	Option exercise M	+200	18.09	17,803	Form 4
2025-09-26	Jones CeciliaChief Financial Officer	Option exercise M	+7,472	–	37,521	Form 4
2025-08-27	Scadden DavidDirector	Option exercise M	+200	18.09	17,803	Form 4
2025-08-11	Smith CynthiaDirector	Option exercise M	+2,302	–	12,414	Form 4
2025-08-11	Ballal Rahul D.Director	Option exercise M	+2,302	–	12,414	Form 4
2025-08-08	Goff BrianDirector, Chief Executive Officer	Option exercise M	+22,691	–	134,613	Form 4
2025-07-10	Scadden DavidDirector	Option exercise M	+1,400	18.09	19,003	Form 4
2025-07-09	Gheuens SarahChief Medical Officer	Option exercise M	+11,914	25.01	73,185	Form 4
2025-07-01	Gheuens SarahChief Medical Officer	Option exercise M	+8,374	–	65,362	Form 4
2025-06-24	Goff BrianDirector, Chief Executive Officer	Option exercise M	+25,527	–	117,872	Form 4
2025-06-24	Goff BrianDirector, Chief Executive Officer	Option exercise M	+12,750	–	118,151	Form 4
2025-06-24	Milanova TsvetaChief Commercial Officer	Option exercise M	+6,000	–	28,892	Form 4
2025-06-24	Jones CeciliaChief Financial Officer	Option exercise M	+6,000	–	31,829	Form 4
2025-06-24	Gheuens SarahChief Medical Officer	Option exercise M	+6,000	–	59,897	Form 4
2025-06-24	Burns James WilliamChief Legal Officer	Option exercise M	+6,000	–	31,449	Form 4
2025-06-20	Smith CynthiaDirector	Option exercise M	+2,120	–	10,112	Form 4
2025-06-20	Scadden DavidDirector	Option exercise M	+2,120	–	17,603	Form 4
2025-06-20	Owen Adams CatherineDirector	Option exercise M	+2,120	–	6,073	Form 4
2025-06-20	Ho MaykinDirector	Option exercise M	+2,120	–	17,032	Form 4
2025-06-20	Fouse Jacqualyn ADirector	Option exercise M	+2,120	–	151,340	Form 4
2025-06-20	Foster-Cheek Kaye IDirector	Option exercise M	+2,120	–	7,468	Form 4
2025-06-20	Capello Jeffrey DDirector	Option exercise M	+2,120	–	6,073	Form 4
2025-06-20	Ballal Rahul D.Director	Option exercise M	+2,120	–	10,112	Form 4
2025-06-13	Owen Adams CatherineDirector	Option exercise M	+1,977	–	3,953	Form 4
2025-06-13	Capello Jeffrey DDirector	Option exercise M	+1,977	–	3,953	Form 4
2025-04-08	Fouse Jacqualyn ADirector	Option exercise M	+15,933	–	156,717	Form 4
2025-03-01	Washburn Theodore James Jr.Principal Accounting Officer	Option exercise M	+777	–	6,269	Form 4
2025-03-01	Washburn Theodore James Jr.Principal Accounting Officer	Option exercise M	+2,350	–	8,388	Form 4
2025-03-01	Washburn Theodore James Jr.Principal Accounting Officer	Option exercise M	+2,450	–	10,141	Form 4
2025-03-01	Gheuens SarahChief Medical Officer	Option exercise M	+3,833	–	48,235	Form 4
2025-03-01	Gheuens SarahChief Medical Officer	Option exercise M	+4,000	–	51,098	Form 4
2025-03-01	Gheuens SarahChief Medical Officer	Option exercise M	+5,667	–	55,578	Form 4
2025-03-01	Goff BrianDirector, Chief Executive Officer	Option exercise M	+8,500	–	87,292	Form 4
2025-03-01	Goff BrianDirector, Chief Executive Officer	Option exercise M	+18,000	–	101,139	Form 4
2025-03-01	Milanova TsvetaChief Commercial Officer	Option exercise M	+5,667	–	24,573	Form 4
2025-03-01	Jones CeciliaChief Financial Officer	Option exercise M	+2,000	–	22,437	Form 4
2025-03-01	Jones CeciliaChief Financial Officer	Option exercise M	+5,667	–	27,510	Form 4
2025-03-01	Burns James WilliamChief Legal Officer	Option exercise M	+3,833	–	19,787	Form 4
2025-03-01	Burns James WilliamChief Legal Officer	Option exercise M	+4,000	–	22,650	Form 4
2025-03-01	Burns James WilliamChief Legal Officer	Option exercise M	+5,667	–	27,130	Form 4
2025-02-01	Washburn Theodore James Jr.Principal Accounting Officer	Option exercise M	+6,896	–	7,709	Form 4
2025-01-03	Milanova TsvetaChief Commercial Officer	Option exercise M	+8,476	–	21,710	Form 4
2024-12-11	Scadden DavidDirector	Option exercise M	+200	18.09	15,683	Form 4
2024-11-08	Ballal Rahul D.Director	Option exercise M	+10,000	25.99	17,992	Form 4
2024-11-07	Ballal Rahul D.Director	Option exercise M	+10,000	25.99	17,992	Form 4

How to read it

Buy, sale: Code P and S on the form: shares bought or sold in the market, at the market price. The other codes are mostly pay (a grant, an option exercised) or tax (shares the company withheld), and say little about what the insider thinks of the price.
Plan: A sale or purchase under a Rule 10b5-1 plan, set up in advance and running on its own schedule. Since April 2023 the form has a box for it. Much executive selling is planned and says more about diversifying than about the company.
Holds after: The shares the insider still held after the trade, in the form the trade was in (directly, or indirectly through a trust or a fund).
Value: Shares times the price the form reports, which is often an average over several fills on the day.

Read from the SEC's own quarterly data sets of Forms 3, 4 and 5, and from each day's filings since the last one. A correcting amendment replaces the lines it restates. Every row links to its filing. None of this is advice: insiders sell for many reasons, and buy for fewer.

Agios Pharmaceuticals's scores and multiples ›